Solna, Sweden · Founded 2006 · Privately Held (backing)
Developer of pharmaceutical drugs designed to treat cognitive neurological disorders. Umecrine Cognition is based in Solna, Sweden and was founded in 2006. Its last reported valuation was $71.5 million in Jul 2021. It has raised $28.1 million.
Last reported valuation
$71.5M
Oct 2026
Priced at
—
Total raised
$28.1M
Last round
—
Team — not yet on record
No current team members for Umecrine Cognition are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Umecrine Cognition with a free account
·Watch Umecrine Cognition: the Monday email on marks, rounds and moves
